NO20003284L - Farmasøytisk preparat for oral administrering - Google Patents

Farmasøytisk preparat for oral administrering

Info

Publication number
NO20003284L
NO20003284L NO20003284A NO20003284A NO20003284L NO 20003284 L NO20003284 L NO 20003284L NO 20003284 A NO20003284 A NO 20003284A NO 20003284 A NO20003284 A NO 20003284A NO 20003284 L NO20003284 L NO 20003284L
Authority
NO
Norway
Prior art keywords
oral administration
pharmaceutical preparation
pharmaceutical
preparation
oral
Prior art date
Application number
NO20003284A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003284D0 (no
Inventor
Claude Aleman
Philippe Bastard
Marielle Bonnel
Thierry Breul
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20003284D0 publication Critical patent/NO20003284D0/no
Publication of NO20003284L publication Critical patent/NO20003284L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
NO20003284A 1997-12-24 2000-06-22 Farmasøytisk preparat for oral administrering NO20003284L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716529A FR2772614B1 (fr) 1997-12-24 1997-12-24 Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
PCT/FR1998/002712 WO1999033466A1 (fr) 1997-12-24 1998-12-14 Composition pharmaceutique buvable

Publications (2)

Publication Number Publication Date
NO20003284D0 NO20003284D0 (no) 2000-06-22
NO20003284L true NO20003284L (no) 2000-08-24

Family

ID=9515152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003284A NO20003284L (no) 1997-12-24 2000-06-22 Farmasøytisk preparat for oral administrering

Country Status (25)

Country Link
US (1) US6191137B1 (de)
EP (1) EP1041984B1 (de)
JP (1) JP2002510599A (de)
AR (1) AR017722A1 (de)
AT (1) ATE252384T1 (de)
AU (1) AU1880599A (de)
BR (1) BR9814414A (de)
CA (1) CA2315696C (de)
CO (1) CO4970813A1 (de)
DE (1) DE69819203T2 (de)
DK (1) DK1041984T3 (de)
DZ (1) DZ2676A1 (de)
ES (1) ES2209238T3 (de)
FR (1) FR2772614B1 (de)
GT (1) GT199800204A (de)
HU (1) HUP0101012A3 (de)
MY (1) MY117156A (de)
NO (1) NO20003284L (de)
PT (1) PT1041984E (de)
SA (2) SA99191003B1 (de)
SI (1) SI1041984T1 (de)
TW (1) TW536409B (de)
UY (1) UY25320A1 (de)
WO (1) WO1999033466A1 (de)
ZA (1) ZA9811824B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087870A2 (en) * 2003-03-25 2004-10-14 The Johns Hopkins University Neuronal cell lineages and methods of production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Also Published As

Publication number Publication date
HUP0101012A3 (en) 2002-12-28
ATE252384T1 (de) 2003-11-15
SI1041984T1 (en) 2004-04-30
SA99191002B1 (ar) 2006-03-07
CO4970813A1 (es) 2000-11-07
NO20003284D0 (no) 2000-06-22
US6191137B1 (en) 2001-02-20
SA99191003B1 (ar) 2006-10-02
DZ2676A1 (fr) 2004-09-19
CA2315696A1 (en) 1999-07-08
TW536409B (en) 2003-06-11
WO1999033466A1 (fr) 1999-07-08
FR2772614B1 (fr) 2000-03-10
HUP0101012A2 (hu) 2001-08-28
ZA9811824B (en) 1999-06-29
BR9814414A (pt) 2000-10-10
DK1041984T3 (da) 2004-02-16
EP1041984B1 (de) 2003-10-22
ES2209238T3 (es) 2004-06-16
UY25320A1 (es) 2000-10-31
DE69819203D1 (de) 2003-11-27
AR017722A1 (es) 2001-09-12
JP2002510599A (ja) 2002-04-09
MY117156A (en) 2004-05-31
FR2772614A1 (fr) 1999-06-25
PT1041984E (pt) 2004-02-27
EP1041984A1 (de) 2000-10-11
DE69819203T2 (de) 2004-07-15
CA2315696C (en) 2008-01-29
AU1880599A (en) 1999-07-19
GT199800204A (es) 2000-06-14

Similar Documents

Publication Publication Date Title
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO973612D0 (no) Nytt farmasöytisk preparat
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20014035D0 (no) System for oral administrasjon av medikament
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
FI963984L (fi) Uusi oraalinen farmaseuttinen annostelumuoto
NO996372D0 (no) Fast farmasoeytisk preparat inneholdende benzofuanderivater
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
NO20005399L (no) Farmasöytisk preparat
ATE432707T1 (de) Pharmazeutische zubereitung
NO20015149L (no) Nytt farmasöytisk preparat
PT868911E (pt) Formulacoes de rapamicina para administracao oral
NO20015148D0 (no) Nytt farmasöytisk preparat
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
NO973610D0 (no) Nytt farmasöytisk preparat
NO996044L (no) Rapamycinformuleringer for oral administrasjon
NO992999D0 (no) Farmas°ytisk blanding for oral administrering
NO20015104L (no) Nytt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
NO20015105L (no) Nytt farmasöytisk preparat
NO950950D0 (no) Farmasöytisk preparat
NO20021036L (no) Farmasöytisk preparat
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application